ONT — Oxford Nanopore Technologies Share Price
Last trade - 00:00- £1.13bn
- £834.07m
- £183.19m
- 37
- 12
- 46
- 18
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.92 | ||
| Price to Tang. Book | 2.08 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 6.15 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -24.27% | ||
| Return on Equity | -23.77% | ||
| Operating Margin | -83.55% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | £m | 113.86 | 133.66 | 198.6 | 169.67 | 183.19 | 227.66 | 292.46 | 28.61% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Oxford Nanopore Technologies plc is engaged in the generation of molecular sensing technology based on nanopores. The Company has developed a deoxyribonucleic (DNA)/ ribonucleic acid (RNA) sequencing technology. The Company’s segments include Life Science Research Tools, which offers products and services for research use, and COVID Testing, which provides products for SAR-Cov-2 testing. Its sequencing technology offers real-time analysis, in fully scalable formats from pocket to population scale, that can analyze native DNA or RNA and sequence any length of fragment to achieve short to ultra-long read lengths. Its products include MinION, GridION, PromethION, Flongle and others. MinION is a real-time device for DNA and RNA sequencing. GridION is a benchtop device designed to run and analyze up to five MinION or Flongle Flow Cells. Flongle is an adapter for MinION or GridION that enables direct, real-time DNA sequencing, or cDNA sequencing on smaller, single-use flow cells.
Directors
- Peter Allen CHM
- Gurdial Sanghera CEO
- Timothy Cowper CFO
- Sarah Lapworth CHO
- John Schoellerman SVP
- Clive Brown CTO
- John Milton CSO
- Jordan Herman VPR
- Zoe McDougall VPR
- James Willcocks EDR
- Alan Aubrey NED (59)
- Guy Harmelin NED
- Adrian Hennah NED
- John O'Higgins NED
- Sarah Wild NED (62)
- Wendy Becker NID (56)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- March 9th, 2005
- Public Since
- September 30th, 2021
- No. of Employees
- 1,281
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- London Stock Exchange
- Shares in Issue
- 955,447,255
- Address
- Oxford Science Park, OXFORD, OX4 4DQ
- Web
- https://www.nanoporetech.com/
- Phone
- Auditors
- Deloitte LLP
Latest News for ONT
Upcoming Events for ONT
Oxford Nanopore Technologies PLC Annual Shareholders Meeting
Oxford Nanopore Technologies PLC Annual Shareholders Meeting
Half Year 2025 Oxford Nanopore Technologies PLC Trading Statement Release
Half Year 2025 Oxford Nanopore Technologies PLC Earnings Release
Similar to ONT
Abingdon Health
London Stock Exchange
Advanced Medical Solutions
London Stock Exchange
Angle
London Stock Exchange
Aoti
London Stock Exchange
Aptamer
London Stock Exchange
FAQ
As of Today at 22:31 UTC, shares in Oxford Nanopore Technologies are trading at 117.90p. This share price information is delayed by 15 minutes.
Shares in Oxford Nanopore Technologies last closed at 117.90p and the price had moved by +19.21% over the past 365 days. In terms of relative price strength the Oxford Nanopore Technologies share price has outperformed the FTSE All Share Index by +14.53% over the past year.
The overall consensus recommendation for Oxford Nanopore Technologies is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreOxford Nanopore Technologies does not currently pay a dividend.
Oxford Nanopore Technologies does not currently pay a dividend.
Oxford Nanopore Technologies does not currently pay a dividend.
To buy shares in Oxford Nanopore Technologies you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 117.90p, shares in Oxford Nanopore Technologies had a market capitalisation of £1.13bn.
Here are the trading details for Oxford Nanopore Technologies:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: ONT
Based on an overall assessment of its quality, value and momentum Oxford Nanopore Technologies is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Oxford Nanopore Technologies is 172.50p. That is 46.31% above the last closing price of 117.90p.
Analysts covering Oxford Nanopore Technologies currently have a consensus Earnings Per Share (EPS) forecast of -£0.14 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Oxford Nanopore Technologies. Over the past six months, its share price has underperformed the FTSE All Share Index by -16.4%.
As of the last closing price of 117.90p, shares in Oxford Nanopore Technologies were trading -9.6% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Oxford Nanopore Technologies PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at 117.90p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Oxford Nanopore Technologies' management team is headed by:
- Peter Allen - CHM
- Gurdial Sanghera - CEO
- Timothy Cowper - CFO
- Sarah Lapworth - CHO
- John Schoellerman - SVP
- Clive Brown - CTO
- John Milton - CSO
- Jordan Herman - VPR
- Zoe McDougall - VPR
- James Willcocks - EDR
- Alan Aubrey - NED
- Guy Harmelin - NED
- Adrian Hennah - NED
- John O'Higgins - NED
- Sarah Wild - NED
- Wendy Becker - NID